CAG Merger with G5F Brings Powerful Dynamic
FOR IMMEDIATE RELEASE
LA JOLLA, CA, November 30, 2018 — The Center for Advanced Genetics (CAG) recently announced its acquisition by Gen 5 Fertility (G5F), transferring its complete IVF portfolio to G5F.
Previously situated near Carlsbad Research Park as a small, boutique IVF clinic, CAG has celebrated healthy IVF baby arrivals for several years with Dr. Sills serving as Chairman & Medical Director. Now, this IVF activity will carry forward at G5F’s ultramodern 17,000sqft oceanfront facility in La Jolla. CAG will no longer offer IVF independently, a move designed to permit CAG to focus exclusively on clinical research–particularly “Ovarian Rejuvenation” with autologous platelet rich plasma (PRP) and specialized laparoscopy for Essure removal.
Dr. Scott Sills will maintain a full-time IVF practice and join world-renowned IVF pioneer Samuel H. Wood, MD PhD becoming Sr Vice President for Research at G5F. Dr. Sills noted, “We are very excited to continue CAG’s academic work under the G5F banner. This alignment assures our path-breaking infertility treatments will help set the global standard. The leadership and vision provided by Dr. Wood, together with CAG’s published research efforts, promise a synergy to lift the chances of a healthy pregnancy with IVF even higher”.
About Dr. Sills, G5F and CAG
A Vanderbilt graduate, Dr. Sills obtained his PhD from London’s University of Westminster. He was awarded the MD degree from University of Tennessee (1992), followed by gynecology residency at NYU Downtown Hospital and a sub-specialty fellowship in reproductive endocrinology at Cornell University-New York Presbyterian Hospital.
Dr. Sills has practiced IVF both in Europe and the United States, with several notable contributions. He was Director for Research Programs at Sims Institute-Dublin (2008-2011), where he led his team’s academic output in reproductive biology to a level exceeding all five Irish medical schools combined. In the arena of E.U. public policy, Dr. Sills’ 2009 expert brief clarifying the status of non-transferred embryos correctly anticipated a landmark Supreme Court decision with major implications for fertility practice. His IVF data were included in the NHS’ Clinical Guidelines for Fertility Assessment & Treatment (London, 2004), while his paper on identical twins was cited by the World Health Organization’s “Current practices in ART” (Geneva, 2002). The New Zealand Ministry of Health incorporated Dr. Sills’ paper on assisted hatching in its national IVF guidelines (Wellington, 2005), and his Lancet report detailing asylum protection for forced sterilization victims (1998) was hailed by the Office of the U.N. High Commissioner for Refugees.
Other widely cited works by Dr. Sills include the first IVF surrogacy births in Ireland (2009), the first description of Irish births from dual anonymous gamete donation (2010), the world’s first report on IVF births in premature ovarian failure using oocytes donated from a twin sister (2010), as well as Ireland’s first deliveries after frozen surgically-retrieved sperm (2011). While on faculty at the Royal College of Surgeons in Ireland, Dr Sills refined a two-stage sequential embryo transfer technique (2012) with healthy term livebirth—another national first.
Previously, Dr. Sills chaired an initiative bridging Arab and Israeli fertility clinics across 13 countries—the first collaboration of its kind in the Middle East (2007). He is believed to be the only fertility expert in the world to have delivered invited lectures both in Tehran and at the U.S. Military Academy-West Point.
Books by Dr. Sills include Fighting at the Fertility Front, an infertility guide specifically for U.S. military, veterans, and their partners (2014). His book Screening the Single Euploid Embryo: Molecular Genetics in Reproductive Medicine (Springer AG; Switzerland) collects the worldwide experience to make IVF safer, simpler, and more successful. In 2016, Cambridge University Press commissioned a comprehensive textbook on cross-border gestational surrogacy, a volume Dr. Sills edited covering clinical practice & international health policy issues.
In addition to books, Dr. Sills has published more than 100 peer-reviewed scientific papers including discovery of three previously unknown human gene mutations. He is board certified both by the American Board of Obstetrics & Gynecology and the National Board of Physicians & Surgeons. Dr Sills is a Fellow of the American College of Obstetricians & Gynecologists, American College of Surgeons, and the Royal College of Physicians (Ireland), holding medical credentials in California, New York and the United Kingdom.